Dogukan Akkus
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Dogukan Akkus has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Eren Berber
Center for Endocrine Surgery, Cleveland Clinic, Cleveland, USA
2 shared publications Arturan Ibrahimli
Center for Endocrine Surgery, Integrated Surgical Institute, Cleveland Clinic, Cleveland, OH, USA
1 shared publicationBeren Berber
Duke University, Durham, North Carolina, USA
1 shared publicationEdip Memisoglu
Center for Endocrine Surgery, Integrated Surgical Institute, Cleveland Clinic, Cleveland, OH, USA
1 shared publication- Emre Teke
University of Health Sciences. Gaziantep City Hospital. General Surgery Department, Gaziantep,Turkey
1 shared publication - Evren Besler
Department of General Surgery, Haydarpasa Numune Training and Research Hospital, University of Health Sciences, Istanbul 34668, Turkey
1 shared publication
Latest Publications
- Open Access
- 18 August 2026
- Published by Elsevier in The American Journal of Surgery
- Vol. 261, 117205
Feasibility of combined near infrared autofluorescence and indocyanine green fluorescence imaging in the management of parathyroid glands
- 18 August 2026
- Published by Elsevier in The American Journal of Surgery
- Vol. 261, 117205
Open AccessFeasibility of combined near infrared autofluorescence and indocyanine green fluorescence imaging in the management of parathyroid glands
- Open Access
Updates on Minimally Invasive Treatment of Adrenal Tumors
Adrenal tumors are increasingly diagnosed due to widespread use of cross-sectional imaging and an aging population, making adrenalectomy a progressively more common surgical procedure. Over the past three decades, adrenal surgery has undergone a paradigm shift from open adrenalectomy to minimally invasive (MI) techniques, with laparoscopic adrenalectomy becoming the standard approach for most benign and selected malignant adrenal tumors. More recently, retroperitoneoscopic and robotic approaches have expanded the armamentarium available to adrenal surgeons, allowing for tailored, patient-specific surgical strategies. This review summarizes current evidence on MI adrenalectomy techniques, including transperitoneal and retroperitoneal laparoscopic approaches, hand-assisted adrenalectomy, and robotic adrenalectomy, with particular emphasis on their role in pheochromocytoma and adrenocortical carcinoma. In addition, evolving ancillary technologies such as laparoscopic ultrasound, indocyanine green fluorescence imaging, artificial intelligence, and virtual and augmented reality are reviewed, highlighting their potential to enhance intraoperative decision-making, safety, and surgical precision. Current controversies, including the role of preoperative alpha-blockade, partial versus total adrenalectomy in hereditary pheochromocytoma, the oncologic adequacy of MI surgery for adrenocortical carcinoma, and the selective use of lymph node dissection, are discussed. Available evidence supports MI adrenalectomy as a safe and effective approach in carefully selected patients when performed by experienced surgeons in high-volume centers. Technological innovations continue to refine surgical planning, execution, and training, suggesting that the future of adrenal surgery will increasingly rely on precision-guided, personalized, and data-driven strategies. This review offers a timely and comprehensive synthesis of the evolving landscape of MI adrenalectomy, uniquely integrating current evidence across the full spectrum of surgical techniques with a critical appraisal of emerging ancillary technologies while addressing unresolved clinical controversies relevant to contemporary surgical practice.
Open AccessUpdates on Minimally Invasive Treatment of Adrenal Tumors
Adrenal tumors are increasingly diagnosed due to widespread use of cross-sectional imaging and an aging population, making adrenalectomy a progressively more common surgical procedure. Over the past three decades, adrenal surgery has undergone a paradigm shift from open adrenalectomy to minimally invasive (MI) techniques, with laparoscopic adrenalectomy becoming the standard approach for most benign and selected malignant adrenal tumors. More recently, retroperitoneoscopic and robotic approaches have expanded the armamentarium available to adrenal surgeons, allowing for tailored, patient-specific surgical strategies. This review summarizes current evidence on MI adrenalectomy techniques, including transperitoneal and retroperitoneal laparoscopic approaches, hand-assisted adrenalectomy, and robotic adrenalectomy, with particular emphasis on their role in pheochromocytoma and adrenocortical carcinoma. In addition, evolving ancillary technologies such as laparoscopic ultrasound, indocyanine green fluorescence imaging, artificial intelligence, and virtual and augmented reality are reviewed, highlighting their potential to enhance intraoperative decision-making, safety, and surgical precision. Current controversies, including the role of preoperative alpha-blockade, partial versus total adrenalectomy in hereditary pheochromocytoma, the oncologic adequacy of MI surgery for adrenocortical carcinoma, and the selective use of lymph node dissection, are discussed. Available evidence supports MI adrenalectomy as a safe and effective approach in carefully selected patients when performed by experienced surgeons in high-volume centers. Technological innovations continue to refine surgical planning, execution, and training, suggesting that the future of adrenal surgery will increasingly rely on precision-guided, personalized, and data-driven strategies. This review offers a timely and comprehensive synthesis of the evolving landscape of MI adrenalectomy, uniquely integrating current evidence across the full spectrum of surgical techniques with a critical appraisal of emerging ancillary technologies while addressing unresolved clinical controversies relevant to contemporary surgical practice.
- 8 April 2026
- Published by SAGE Publications in Journal of Laparoendoscopic & Advanced Surgical Techniques
- Vol. 36 (7) , 506-510
Utility of Indocyanine Green in Intraoperative Imaging of Adrenal Tumors
Backgrounds: Indocyanine green (ICG) is a fluorescent biocompatible dye that emits light in the near-infrared spectrum upon excitation, enabling real-time visualization of vascular anatomy and tissue perfusion during surgery. Its favorable safety profile and rapid pharmacokinetics have led to widespread adoption across surgical specialties. More recently, ICG fluorescence imaging has been utilized for tumor localization in adrenalectomy, improving intraoperative decision-making, particularly in complex anatomical regions. Methods: A comprehensive literature search was conducted using PubMed, EMBASE, and Google Scholar databases. Tailored search strategies were applied for each topic addressed in this review. Articles were considered eligible for inclusion if they met the following criteria: (1) original research studies, randomized controlled trials, or systematic reviews with or without meta-analysis; (2) studies involving human subjects; and (3) publications in the English language. All selected studies underwent independent review by 2 authors, and any discrepancies were resolved through discussion with a third reviewer. Results: ICG fluorescence imaging is a valuable adjunct for adrenal gland identification, as the adrenal cortex demonstrates strong fluorescence due to its rich vascularization, allowing clear differentiation from surrounding retroperitoneal tissue. Adrenocortical tumors typically exhibit a hyperfluorescent pattern, whereas medullary tumors and malignant lesions more commonly demonstrate hypofluorescence, likely reflecting differences in their underlying biochemical and anatomical characteristics. Furthermore, ICG is particularly useful in partial adrenalectomy for bilateral tumors, facilitating precise tumor localization and resection while preserving functional adrenal cortical tissue. Conclusions: ICG fluorescence imaging is a valuable adjunct in adrenal surgery, enabling real-time visualization of adrenal anatomy, vascular structures, and tissue perfusion. Its application improves gland identification, facilitates accurate tumor localization, and supports cortical-sparing approaches by preserving functional adrenal tissue.
- 8 April 2026
- Published by SAGE Publications in Journal of Laparoendoscopic & Advanced Surgical Techniques
- Vol. 36 (7) , 506-510
Utility of Indocyanine Green in Intraoperative Imaging of Adrenal Tumors
Backgrounds: Indocyanine green (ICG) is a fluorescent biocompatible dye that emits light in the near-infrared spectrum upon excitation, enabling real-time visualization of vascular anatomy and tissue perfusion during surgery. Its favorable safety profile and rapid pharmacokinetics have led to widespread adoption across surgical specialties. More recently, ICG fluorescence imaging has been utilized for tumor localization in adrenalectomy, improving intraoperative decision-making, particularly in complex anatomical regions. Methods: A comprehensive literature search was conducted using PubMed, EMBASE, and Google Scholar databases. Tailored search strategies were applied for each topic addressed in this review. Articles were considered eligible for inclusion if they met the following criteria: (1) original research studies, randomized controlled trials, or systematic reviews with or without meta-analysis; (2) studies involving human subjects; and (3) publications in the English language. All selected studies underwent independent review by 2 authors, and any discrepancies were resolved through discussion with a third reviewer. Results: ICG fluorescence imaging is a valuable adjunct for adrenal gland identification, as the adrenal cortex demonstrates strong fluorescence due to its rich vascularization, allowing clear differentiation from surrounding retroperitoneal tissue. Adrenocortical tumors typically exhibit a hyperfluorescent pattern, whereas medullary tumors and malignant lesions more commonly demonstrate hypofluorescence, likely reflecting differences in their underlying biochemical and anatomical characteristics. Furthermore, ICG is particularly useful in partial adrenalectomy for bilateral tumors, facilitating precise tumor localization and resection while preserving functional adrenal cortical tissue. Conclusions: ICG fluorescence imaging is a valuable adjunct in adrenal surgery, enabling real-time visualization of adrenal anatomy, vascular structures, and tissue perfusion. Its application improves gland identification, facilitates accurate tumor localization, and supports cortical-sparing approaches by preserving functional adrenal tissue.
- Open Access
- 1 January 2023
- Published by XMLink in Annals of Surgical Treatment and Research
- Vol. 105 (3) , 165-171
A new risk scoring system for early prediction of surgical need in patients with adhesive small bowel obstruction: a single-center retrospective clinical study
Besler E, et al. Ann Surg Treat Res. 2023 Sep;105(3):165-171. https://doi.org/10.4174/astr.2023.105.3.165
- 1 January 2023
- Published by XMLink in Annals of Surgical Treatment and Research
- Vol. 105 (3) , 165-171
Open AccessA new risk scoring system for early prediction of surgical need in patients with adhesive small bowel obstruction: a single-center retrospective clinical study
Besler E, et al. Ann Surg Treat Res. 2023 Sep;105(3):165-171. https://doi.org/10.4174/astr.2023.105.3.165
- Open Access
- 28 November 2022
- Published by Springer Nature in Obesity Surgery
- Vol. 33 (1) , 25-31
Assessment of Exocrine Pancreatic Function Following Bariatric/Metabolic Surgery: a Prospective Cohort Study
Background: Exocrine pancreatic insufficiency (EPI) can be seen after bariatric/metabolic surgery. Fecal elastase level is a simple test in diagnosing and grading EPI. Quality of life changes in patients with bariatric/metabolic surgery related to gastrointestinal complaints is debated. Aim: This study aimed to investigate rates and grades of EPI via fecal elastase levels and association between EPI and quality of life in bariatric surgery patients. Methods: A prospective study was performed for patients with bariatric/metabolic surgery at their second-year follow-up. Fecal elastase levels were used to diagnose and grade EPI as severe or moderate. Patient’s gastrointestinal quality of life index (GIQLI) was calculated. Patients were grouped as sleeve gastrectomy (SG), one-anastomosis gastric bypass (OAGB), single-anastomosis sleeve ileal bypass (SASI), and transit bipartition (TB). Rates of severe or moderate EPI were primary outcome. Secondary outcome was an association between fecal elastase and GIQLI. Results: There were 17, 29, 21, and 15 patients in OAGB, SG, TB, and SASI groups. There was no significant difference between groups in GIQLI scores and fecal elastase levels (p = 0.152 and p = 0.361). Rates of patients with moderate EPI in the groups OAGB, SG, TB, and SASI were 23.5%, 17.2%, 14.3%, and 20.0%. GIQLI scores were not significantly correlated with age, postoperative morphometric data, and fecal elastase values (p > 0.05). Conclusion: Rates of patients with moderate EPI ranged from 14.3 to 23.5% at second-year follow-up. There was no patient with severe EPI. GIQLI scores were not significantly correlated with fecal elastase levels and different types of bariatric/metabolic surgery. Graphical
- 28 November 2022
- Published by Springer Nature in Obesity Surgery
- Vol. 33 (1) , 25-31
Open AccessAssessment of Exocrine Pancreatic Function Following Bariatric/Metabolic Surgery: a Prospective Cohort Study
Background: Exocrine pancreatic insufficiency (EPI) can be seen after bariatric/metabolic surgery. Fecal elastase level is a simple test in diagnosing and grading EPI. Quality of life changes in patients with bariatric/metabolic surgery related to gastrointestinal complaints is debated. Aim: This study aimed to investigate rates and grades of EPI via fecal elastase levels and association between EPI and quality of life in bariatric surgery patients. Methods: A prospective study was performed for patients with bariatric/metabolic surgery at their second-year follow-up. Fecal elastase levels were used to diagnose and grade EPI as severe or moderate. Patient’s gastrointestinal quality of life index (GIQLI) was calculated. Patients were grouped as sleeve gastrectomy (SG), one-anastomosis gastric bypass (OAGB), single-anastomosis sleeve ileal bypass (SASI), and transit bipartition (TB). Rates of severe or moderate EPI were primary outcome. Secondary outcome was an association between fecal elastase and GIQLI. Results: There were 17, 29, 21, and 15 patients in OAGB, SG, TB, and SASI groups. There was no significant difference between groups in GIQLI scores and fecal elastase levels (p = 0.152 and p = 0.361). Rates of patients with moderate EPI in the groups OAGB, SG, TB, and SASI were 23.5%, 17.2%, 14.3%, and 20.0%. GIQLI scores were not significantly correlated with age, postoperative morphometric data, and fecal elastase values (p > 0.05). Conclusion: Rates of patients with moderate EPI ranged from 14.3 to 23.5% at second-year follow-up. There was no patient with severe EPI. GIQLI scores were not significantly correlated with fecal elastase levels and different types of bariatric/metabolic surgery. Graphical